Progression of Ebola Therapeutics During the 2014-2015 Outbreak

Trends in Molecular Medicine
Emelissa J MendozaGary Kobinger

Abstract

The recent Ebola virus (EBOV) outbreak in West Africa was the deadliest EBOV epidemic in history, highlighting the need for a safe and efficacious treatment against EBOV disease (EVD). In the absence of an approved treatment, experimental drugs were utilized under compassionate grounds hoping to diminish EVD-associated morbidity and mortality. As more data were collected from safety studies, Phase II/III clinical trials were introduced in Guinea, Sierra Leone, and Liberia to test promising candidates, including small-molecule drugs, RNA-based treatments, and antibody-based therapies. In this review, we summarize the use of, and preliminary observations from, current clinical trials with EVD therapeutics, shedding light on experimental drug selection, emergency clinical evaluation, and the impact these factors may have on future infectious disease outbreaks.

References

Mar 12, 1999·The Journal of General Virology·V E VolchkovH Feldmann
Nov 6, 2004·Nature Biotechnology·Stephan HellwigRainer Fischer
Jun 26, 2007·PLoS Pathogens·Joost HaasnootBen Berkhout
Dec 6, 2007·The Journal of Infectious Diseases·Peter B JahrlingThomas W Geisbert
Sep 20, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Xiangguo QiuSteven M Jones
Nov 1, 2011·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·O Erhabor, T C Adias
Mar 14, 2012·Proceedings of the National Academy of Sciences of the United States of America·John M DyeWilliam D Pratt
Jun 16, 2012·Science Translational Medicine·Xiangguo QiuGary P Kobinger
Aug 23, 2012·International Journal of Dermatology·Dieudonné NkogheJean Paul Gonzalez
Sep 27, 2013·The New England Journal of Medicine·Francisco M MartyUNKNOWN CMX001-201 Clinical Study Group
Oct 3, 2013·Antiviral Research·Yousuke FurutaDale L Barnard
Apr 9, 2014·The Journal of Antimicrobial Chemotherapy·Gerrit GehringThomas von Hahn
Aug 19, 2014·Annals of Internal Medicine·Nancy Kass
Nov 8, 2014·Bulletin of the World Health Organization·Ruediger Krech, Marie-Paule Kieny
Nov 11, 2014·Drug Discoveries & Therapeutics·Jianjun Gao, Lin Yin
Nov 13, 2014·The New England Journal of Medicine·G Marshall LyonUNKNOWN Emory Serious Communicable Diseases Unit
Dec 3, 2014·Annals of Emergency Medicine·Linda MeyersChristopher Kang
Feb 14, 2015·Science·Kai Kupferschmidt, Jon Cohen
Apr 10, 2015·The American Journal of Bioethics : AJOB·Arthur L CaplanBruce Levin
Apr 24, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Colleen S KraftUNKNOWN Nebraska Biocontainment Unit and the Emory Serious Communicable Diseases Unit
May 15, 2015·Clinical Microbiology Reviews·Gary Wong, Gary P Kobinger
May 21, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Diana F FlorescuPhilip W Smith
Jun 5, 2015·The Lancet. Respiratory Medicine·Marta Mora-RilloUNKNOWN La Paz-Carlos III University Hospital Isolation Unit
Jun 13, 2015·The Journal of Infectious Diseases·Thomas W GeisbertHeinz Feldmann
Jul 15, 2015·Medicinal Research Reviews·Zlatko Janeba
Jul 24, 2015·The Lancet Infectious Diseases·Manuel SchiblerLaurent Kaiser
Aug 28, 2015·Journal of Virology·Edgar DavidsonBenjamin J Doranz

❮ Previous
Next ❯

Citations

Sep 15, 2016·ACS Infectious Diseases·Courtney C Aldrich
May 18, 2016·Journal of Molecular Biology·Logan BanadygaHideki Ebihara
Jul 10, 2016·Journal of Clinical Apheresis·Jerry F BrownDavid L Hoover
Jan 28, 2017·Future Medicinal Chemistry·Jonathan P WongRiccardo V D'Elia
Mar 14, 2017·Expert Review of Anti-infective Therapy·Cristiano SalataGiorgio Palù
Mar 31, 2017·Immunotherapy·Emelissa J MendozaGary P Kobinger
Jun 4, 2018·The Journal of Infectious Diseases·Kristen E PascalChristos A Kyratsous
Nov 16, 2018·Journal of Medical Virology·Muhammad Usman MirzaMuhammad Idrees
Nov 7, 2019·Nature·Juliet BedfordJohn Nkengasong
Mar 5, 2020·Expert Review of Vaccines·Kyle O'Donnell, Andrea Marzi
Apr 17, 2020·European Journal of Preventive Cardiology·Alberto AimoCarlo Tascini
Nov 18, 2017·Expert Opinion on Biological Therapy·Gary WongXiangguo Qiu
Dec 7, 2017·Expert Review of Anti-infective Therapy·Maryam Keshtkar-JahromiSina Bavari
Dec 14, 2016·Annual Review of Pharmacology and Toxicology·Anthony P CardileSina Bavari
Oct 1, 2019·Annual Review of Virology·Wakako Furuyama, Andrea Marzi
Feb 18, 2021·Expert Opinion on Investigational Drugs·Frederick HansenMichael A Jarvis
May 4, 2017·Bioorganic & Medicinal Chemistry Letters·Mary K YatesKatherine L Seley-Radtke
Oct 21, 2016·Current Opinion in Pharmacology·Anthony P CardileSina Bavari
Feb 22, 2021·European Journal of Preventive Cardiology·Alberto AimoCarlo Tascini
Jun 10, 2016·Clinical Microbiology Reviews·Erik De Clercq, Guangdi Li
May 4, 2017·The Lancet Infectious Diseases·Amanda RojekJake Dunning
Oct 10, 2021·The Journal of Infectious Diseases·Marc-Antoine De La VegaGary P Kobinger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Ligui WangHongbin Song
Expert Opinion on Drug Discovery
Sanja GlisicVeljko Veljkovic
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
Saurabh R ShrivastavaRamasamy Jegadeesh
© 2022 Meta ULC. All rights reserved